• Accueil >
  • Publications >
  • Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis

Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis

11 mai 2021British Journal of Cancer

DOI : 10.1038/s41416-021-01320-1

Auteurs

Monika Sparber-Sauer, Daniel Orbach, Fariba Navid, Simone Hettmer, Stephen Skapek, Nadège Corradini, Michela Casanova, Aaron Weiss, Matthias Schwab, Andrea Ferrari